argenx (NASDAQ: ARGX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -4.970 | -4.360 | 0.6100 | ||||
REV | 16.020M | 21.163M | 5.143M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of argenx (NASDAQ: ARGX) through any online brokerage.
Other companies in argenx’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for argenx (NASDAQ: ARGX) was reported by Stifel on Tuesday, June 28, 2022. The analyst firm set a price target for 460.00 expecting ARGX to rise to within 12 months (a possible 21.97% upside). 20 analyst firms have reported ratings in the last year.
The stock price for argenx (NASDAQ: ARGX) is $377.13 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for argenx.
argenx’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for argenx.
argenx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.